News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biotech Beach
Vical Incorporated to Present at Upcoming Investor Conferences
May 8, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO, May 8, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at two upcoming investor conferences.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Editorial
Eli Lilly and the LA Dodgers: A tale of 2 dynasties
October 8, 2026
·
3 min read
·
Heather McKenzie
Obesity
Zealand dips as Boehringer Ingelheim-partnered weight loss drug fails to impress—again
October 1, 2026
·
2 min read
·
Heather McKenzie
Obesity
Superior weight loss, blood sugar control propel Lilly’s amylin-GIP/GLP-1 combo into Phase 3
September 30, 2026
·
3 min read
·
Heather McKenzie
Psychedelics
Psychedelic therapies ride wave of public favor into FDA hearing
September 14, 2026
·
3 min read
·
Michael Gibney
